Last reviewed · How we verify

NCT03664947

The Impact of Exercise Approaches on Sleep in Children With Acute Lymphoblastic Leukemia

Completed NA Last updated 18 January 2020
What this trial tests

NA trial testing exercise in Oncology Problem in 20 participants. Completed in 31 December 2019.

Timeline
1 October 2019
Primary endpoint
30 November 2019
31 December 2019

Quick facts

Lead sponsorBezmialem Vakif University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 October 2019
Primary completion30 November 2019
Estimated completion31 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

Adults 2 to 18, any sex, with Oncology Problem or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep is one of the basic and indispensable daily life activities that affect the quality of life and health of individuals and is a concept with physiological, psychological and social dimensions. In the literature, sleep difficulties and problems have begun to be investigated in children with acute lymphoblastic leukemia and have not been found in national publications. In these children, sleep quality, strengths and disorders and a study evaluating this variation on a scale have not been found. For this reason, our study will be done in order to determine the factors affecting sleep and sleep in children with cancer and to show the effect of exercise on these factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of exercise

Trials testing the same drug.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03664947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing